Hausauer Amelia K, Keegan Theresa H M, Chang Ellen T, Glaser Sally L, Howe Holly, Clarke Christina A
Northern California Cancer Center, Fremont, CA, USA.
BMC Med. 2009 Jun 26;7:31. doi: 10.1186/1741-7015-7-31.
Unprecedented declines in invasive breast cancer rates occurred in the United States between 2001 and 2004, particularly for estrogen receptor-positive tumors among non-Hispanic white women over 50 years. To understand the broader public health import of these reductions among previously unstudied populations, we utilized the largest available US cancer registry resource to describe age-adjusted invasive and in situ breast cancer incidence trends for non-Hispanic white women aged 50 to 74 years overall and by county-level rural/urban and poverty status.
We obtained invasive and in situ breast cancer incidence data for the years 1997 to 2004 from 29 population-based cancer registries participating in the North American Association of Central Cancer Registries resource. Annual age-adjusted rates were examined overall and by rural/urban and poverty of patients' counties of residence at diagnosis. Joinpoint regression was used to assess trends by annual quarter of diagnosis.
Between 2001 and 2004, overall invasive breast cancer incidence fell 13.2%, with greater reductions among women living in urban (-13.8%) versus rural (-7.5%) and low- (-13.0%) or middle- (-13.8%) versus high- (-9.6%) poverty counties. Most incidence rates peaked around 1999 then declined after second quarter 2002, although in rural counties, rates decreased monotonically after 1999. Similar but more attenuated patterns were seen for in situ cancers.
Breast cancer rates fell more substantially in urban and low-poverty, affluent counties than in rural or high-poverty counties. These patterns likely reflect a major influence of reductions in hormone therapy use after July 2002 but cannot exclude possible effects due to screening patterns, particularly among rural populations where hormone therapy use was probably less prevalent.
2001年至2004年间,美国侵袭性乳腺癌发病率出现了前所未有的下降,尤其是50岁以上非西班牙裔白人女性中雌激素受体阳性肿瘤的发病率。为了解这些下降趋势在以前未研究人群中的更广泛公共卫生意义,我们利用美国最大的可用癌症登记资源,描述了50至74岁非西班牙裔白人女性总体以及按县级农村/城市和贫困状况调整年龄后的侵袭性和原位乳腺癌发病率趋势。
我们从参与北美中央癌症登记协会资源的29个基于人群的癌症登记处获取了1997年至2004年侵袭性和原位乳腺癌发病率数据。按总体以及按诊断时患者居住县的农村/城市和贫困状况检查年度年龄调整率。采用Joinpoint回归按诊断年度季度评估趋势。
2001年至2004年间,总体侵袭性乳腺癌发病率下降了13.2%,城市女性(-13.8%)比农村女性(-7.5%)下降幅度更大,低贫困县(-13.0%)或中等贫困县(-13.8%)比高贫困县(-9.6%)下降幅度更大。大多数发病率在1999年左右达到峰值,然后在2002年第二季度后下降,不过在农村县,发病率在1999年后单调下降。原位癌也出现了类似但更为缓和的模式。
城市和低贫困、富裕县的乳腺癌发病率下降幅度比农村或高贫困县更大。这些模式可能反映了2002年7月后激素治疗使用减少的主要影响,但不能排除筛查模式可能产生的影响,特别是在激素治疗使用可能不太普遍的农村人群中。